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ABSTRACT
P27Kip1 (p27) is a member of the Cip/Kip family of
cyclin-dependent kinase inhibitors. Recently, a
new function of p27 as transcriptional regulator
has been reported. It has been shown that p27 regu-
lates the expression of target genes mostly involved
in splicing, cell cycle, respiration and translation. We
report here that p27 directly binds to the transcrip-
tional coactivator PCAF by a region including amino
acids 91–120. PCAF associates with p27 through its
catalytic domain and acetylates p27 at lysine
100. Our data showed that overexpression of PCAF
induces the degradation of p27 whereas in contrast,
the knockdown of PCAF stabilizes the protein. A p27
mutant in which K100 was substituted by arginine
(p27-K100R) cannot be acetylated by PCAF and
has a half-life much higher than that of p27WT.
Moreover, p27-K100R remains stable along cell-
cycle progression. Ubiquitylation assays and the
use of proteasome inhibitors indicate that PCAF
induces p27 degradation via proteasome. We also
observed that knockdown of skp2 did not affect
the PCAF induced degradation of p27. In conclusion,
our data suggest that the p27 acetylation by PCAF
regulates its stability.
INTRODUCTION
Cell-cycle progression is regulated by the sequential acti-
vation of members of the cyclin-dependent kinase (cdk)
family (1). Quiescent cells contain signiﬁcant levels of
cdk4 and cdk2 but only very small amounts of cyclins.
Since cyclins associate with and activate cdks, quiescent
cells only display very low cdk activity. After mitogenic
stimulation cells synthesize cyclin D that associates with
cdk4 that as a consequence becomes activated (2). The
main function of active cyclin D–cdk4 complexes
at early G1 phase of the cell cycle is to phosphorylate
transcriptional repressor complexes containing E2F4/
p130 or E2F1/pRb that are additionally associated with
different transcriptional corepressors (3,4). In quiescent
cells, these complexes repress the expression of a number
of genes necessary for the onset of DNA replication. Cdk4
phosphorylation of p130, pRb and other proteins of these
complexes at early G1, disorganize some of them allowing
transcription of a number of genes, including cyclin E that
accumulates in the cells at mid-late G1. Then, cyclin
E binds to and activates cdk2 that additionally phosphor-
ylate p130 and pRb to ﬁnally disrupt the repressor
complexes. This leads to the expression of the S phase
genes needed for the onset of DNA synthesis.
In addition to the association with cyclins, cdk activity
is also regulated by phosphorylation, acetylation and by
association with speciﬁc cdk inhibitors (CKIs) (5–7).
There are two families of CKIs: The Cip/Kip family that
includes p21, p27 and p57 and that associate with and
inhibit most cyclin–cdk complexes. In contrast, the
members of the other family (ink4) including p15, p16,
p18 and p19 speciﬁcally bind to and inhibit cdk4 and
cdk6 (5,8).
Among these CKIs, p27 is speciﬁcally relevant because
its deﬁciency is associated with tumorigenesis. Reduced
p27 levels are frequently observed in human cancers in
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association with tumor aggressiveness and poor clinical
outcome (9–11). In most of the cases, low levels of
p27 in human tumors are due to post-transcriptional regu-
lation that leads to an increased proteasome-dependent
degradation (12–14). The role of p27 in tumorigenesis is
supported by the evidence that p27/—mice spontan-
eously develop pituitary tumors and are much more sus-
ceptible to tumorigenesis induced by chemical carcinogens
than p27wt—mice (15–17). Moreover, knock in mice har-
boring a p27 mutant (p27CK), including four punctual mu-
tations that unables it to interact with and to inhibit
cyclin–cdk complexes, develop hyperplasias and tumors
in many different organs (18). These data clearly
indicate that p27 performs other cellular functions,
involved in tumorigenesis, that are independent of its
role as a CKI.
We have recently reported that p27 plays a role as a
transcriptional regulator (19). Speciﬁcally, by ChIP on
chip, we have observed that p27 associates with 427 pro-
moters of genes mainly involved in cell-cycle regulation,
respiration, translation and RNA processing and splicing.
Interestingly, the overexpression of these p27-target genes
(p27-TGs) in human tumors correlates with poor clinical
outcome. These results suggest that the transcriptional
regulatory function of p27 plays an important role in the
development of tumors.
On a signiﬁcant number of these p27-TG promoters p27
is associated with E2F4/p130 repressor complexes.
Interestingly, we found that in fact p27 directly interacts
with E2F4 and p130 by its carboxyl moiety. Thus, p27 is a
structural component of these repressor complexes that
operate in quiescent cells to repress the S phase genes.
According to that, expression microarrays analysis
performed on embryo ﬁbroblasts (MEFs) from
p27WT, p27/ and p27CK revealed that p27 behaves as
a transcriptional repressor of these p27-TGs (19). The
speciﬁc role of p27 on these repressor complexes still
remains to be clariﬁed but a possibility is that in
addition to its repressive role it may also participate in
the recruitment on cyclin–cdk complexes needed for
p130 phosphorylation at early-mid G1 phase. The
evidence showing that the interaction of p27 with E2F4/
p130 complexes is through its carboxyl moiety indicates
that its amino moiety (that contains the cyclin and
cdk interacting domains) will be free to associate with
cyclin–cdk complexes when they will appear at
early G1. However, this possibility still remains to be
clariﬁed.
On searching for nuclear proteins that interact with p27
in quiescent cells we observed that the acetyl transferase
and transcriptional coactivator PCAF (6) associates with
p27 in these cells. We report here that PCAF directly inter-
acts with and acetylates p27 in the K100 residue. We have
identiﬁed the PCAF interacting domain of p27 and
demonstrated that acetylation of p27 by PCAF induces
its degradation via proteasome. These results are compat-
ible with a role of PCAF as a coactivator of p27-TGs by
inducing the degradation of p27, a transcriptional repres-
sor of these genes.
MATERIALS AND METHODS
Materials
ALLNL and MG132 were purchased from Calbiochem.
[14C]acetylCoA from Perkin Elmer. Histones and
cycloheximide were from Sigma-Aldrich. Rabbit reticulo-
cyte extracts (L4151) were from Promega. The following
antibodies were used in this work: Acetyl-Lys
(600-401-939), from Rockland Immunochemicals;
p27Kip1 (sc-528 and sc-527) from Santa Cruz, Bio-
technology and (610242) from BD transduction labs;
cyclin D1 (Sc-20044) and Skp2 (sc-7164) from Santa
Cruz Biotechnology; PCAF (P7493), ubiquitin (U5379)
and Flag (F7425) from Sigma-Aldrich; actin (69100)
from MP Biomedicals; p21Cip1 (OP64) from Calbiochem
and GFP (ab290) from Abcam.
Plasmids
The p21 full length, the full-length p27 and the following
mutants of p27 were purchased from Genscript: p27WT,
p27-K13R in which all lysines of p27 were substituted
for arginines, p27–K5R (K47R,K59R,K68R,K73R,
K81R). p27-K3R (K25R,K96R,K100R), p27–K2R
(K96R,K100R), p27–K100R, p27(91–120), p27(91–
100), p27(96–100) and p27(91–95). All these se-
quences were subsequently subcloned in a pECFP–C1
vector (Clontech). pCDNA3–Flag–PCAF (FlagPCAF),
pCDNA3–GFP–Flag–PCAF (GFPCtWT) and
pCDNA3–GFP–Flag–PCAFHAT (352–832, lacking
amino acids 527–547) (GFP–CtHAT) have been
described elsewhere (20). The shRNA corresponding to
PCAF (pLKO-1, puro-PCAF) and the shRNA random
(pLKO-1, puro) used as a control were from
Sigma-Aldrich. The siRNA corresponding to Skp2 and
to GFP were from Dharmacon.
Recombinant proteins
pGEX vectors (Amersham) containing: the full-length
p27, the different mutants and fragments of this protein,
p21, GST or CBP were transformed into Escherichia coli
BL21 strain. The expressed proteins were subsequently
puriﬁed as previously described (21). The plasmids
pGEX–PCAF (GSTPCAF), pGEX–PCAF(352–658)
(GSTHAT) and pGEXPCAF(352–832, lacking amino
acids 527–547) (GSTCtHAT) have been previously
described (22,23).
Cell culture and transfection
HEK 293T and HeLa cells were cultured in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) (Biological Industries)
containing 10% fetal calf serum (FCS). HCT116 cells were
cultured in DEMEM:HAM (1:1) complemented with
2mM Glutamine, 1% non-essential amino acids, 1mM
piruvic acid and 10% FCS. In some experiments the pro-
teasome inhibitors ALLNL (100mM) or MG132 (10 mM)
were added to the culture medium. Transfection of
HCT116 and HET293T cells was performed with
Lypofectamine 2000 or Lipofect, respectively as directed
by the manufacturer (Qiagen). Cells were harvested 24 h
after transfection. To synchronize the different cellular
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types, they were cultured for 48–72 h in 0.5% FCS media.
Then, cells were replated in media with 10% FCS and
subsequently collected at different times after replating.
Afﬁnity chromatography
To generate the different chromatography columns the
puriﬁed proteins or peptides were covalently bound to
CNBr-activated sepharose 4B, according to the manufac-
turers (Amersham). The peptides used in these experi-
ments were purchased from GenScript. Cell were lysed
with buffer A (50mM HEPES, pH 7.6, 50mM KCl,
1mM EDTA and 1mM MgCl2). Then, cell extracts
(10mg) were loaded onto the columns and after washing
in 50 vol. of buffer A containing 150mM KCl, the bound
proteins were eluted with the same buffer but containing
1.5M KCl (21). Then, they were subsequently eluted with
0.1M Na–acetate and 0.5M NaCl at pH 4.5. To analyze
the direct binding of puriﬁed proteins to the columns the
same protocol was used but loading 5–10 mg of the puriﬁed
proteins onto the columns.
Immunoprecipitation and western blotting
Cells were lysed in RIPA buffer (50mM Tris, pH 7.5,
150mM NaCl, 1mM EDTA, 1% NP40, 0.5%
deoxycolate, 0.1% SDS and 3.3 mM TSA) containing
50mM NaF, 1mM phenylmehylsulfonyl ﬂuoride,
0.1mM Na3VO4, 0.5 mg/ml aprotinin and 10 mg/ml
Leupeptin) for 30min on ice. For the immunopre-
cipitation (IP) experiments, lysates were incubated with
4 mg of speciﬁc antibodies overnight at 4C. Then,
protein A/G agarose beads (Pearce) were added and
samples were incubated for 45min at 4C. After three
washes with RIPA buffer, immunoprecipitates were sub-
jected to western blotting (WB) as described (24).
In vitro acetylation assay
Protein acetyltransferase assays were performed in 30 ml of
HAT lysis buffer (50mM Tris, pH 8.0, 50mM KCl, 5%
glycerol and 1mM EDTA), 1 ml (0.02 mCi) of [14C]-
acetyl-CoA (Perkin Elmer), 6mM of substrate proteins
or histones and 300 ng of recombinant HAT domains of
PCAF or CBP. Reactions were performed for 30min at
30C. Then, proteins were separated by SDS–polyacryl-
amide gel electrophoresis (PAGE), transferred to nitrocel-
lulose membranes and exposed to ﬁlm for 2–4 days.
In vitro ubiquitylation assay
Recombinant GSTp27 and GSTp27K100R were
acetylated with recombinant GSTHAT domain of PCAF
as described above. After acetylation, 60 ml of reticulocyte
cell lysate (Promega) were added to the reaction as a
source of ubiquitin and ubiquitylation enzymes. The
mixture was incubated for 1 h at 37C and then, the re-
combinant GST-fusion substrates were re-puriﬁed using
glutathione–agarose beads (Amersham) as described by
the manufacturer. The GST-fusion substrates were
separated by SDS–PAGE and the presence of
ubiquitylated p27 forms was analyzed by WB using
anti-ubiquitin antibodies. Similar experiments were
performed and the proteins transferred to nitrocelulose
membranes. Then, the radioactivity incorporated into
the proteins was detected by autoradiography for
2–4 days.
Spot mapping analysis
Nine peptides, each one containing one of the lysines
present in the N-terminus of p27 were generated
(Genosys). The selected sequences were: (i)
KSTGGKAPRKQ (histone H3 peptide as a positive con-
trol); (ii) RQAEHPKPSACR; (iii) LTRDLEKHCRDM;
(iv) EEASQRKWNFDF; (v) NFDFQNHKPLEG; (vi)
PLEGKYEWQEVE; (vii) WQEVEKGSLPEF; (viii)
YYRPPRPPKGAC; (ix) GACKVPAQESQD. Peptides
(5 nmol) were spotted on a nitrocellulose membrane and
then the membrane was subjected to an in vitro acetylation
assay as described above.
Protein stability assay
Cells were transfected for 20 h with FlagPCAF expression
vector or with a pCDNA empty vector as a control. Then,
10 mg/ml of cycloheximide (Sigma) were added to the cell
cultures and cells were harvested at different times after
cycloheximide addition. Finally, samples were subjected to
WB using anti-p27, anti-PCAF or anti-actin that was used
as a loading control. Similar experiments were performed
to study the stability of the ectopic p27WT or the non-
acetylatable mutant p27K100R. In these experiments,
HCT116 cells were transfected with pCDNAp27WT or
pCDNAK100R expression vectors or with a pCDNA
empty vector as a control.
Immunoﬂuorescence
To detect CFP–p27 and YFP–PCAF by immunoﬂuores-
cence, HCT116 cells with transfected with vectors contain-
ing these genes and grown in coverslips, ﬁxed in 4%
paraformaldehyde/PBS for 15min at room temperature
and washed in PBS. After ﬁxation, cells were stained
with DAPI for the nuclear visualization. Then, coverslips
were mounted on glass slides with Mowiol (Calbiochem)
and analyzed by ﬂuorescence microscopy.
RESULTS
The protein p27 interacts with the acetyltransferase PCAF
To identify new p27-binding proteins, extracts from
HCT116 cells were loaded on a p27–Sepharose 4B
column and the proteins associated with p27 were subse-
quently eluted and analyzed by mass spectrometry.
A protein of 89 kDa from the eluates was identiﬁed as
PCAF by mass spectrometry (data not shown). The
binding of PCAF to the p27 column was conﬁrmed by
WB (Figure 1A). Direct in vitro interaction between
PCAF and p27 was examined by afﬁnity chromatography.
Puriﬁed recombinant GST–PCAF or the catalytic domain
of PCAF (GST–HAT), were separately loaded on a p27
column and the binding analyzed. Results showed that
both, full-length PCAF (Figure 1B) and the HAT
domain (Figure 1C) associated with the p27 column,
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indicating that PCAF directly interacts with p27 by its
catalytic domain. Colocalization experiments were subse-
quently performed in HCT116 cells cotransfected with
CFP–p27 and YFP–PCAF. As shown in Figure 1D both
proteins colocalize in the nucleus. To determine whether
p27 and PCAF interact in the cells, we used HEK 293T
cells that were cotransfected with YFP–Flag–PCAF and
CFP–p27. Then, IP with anti-Flag were performed.
Results showed the co-IP of both proteins (Figure 1E).
We also observed the co-IP of the endogenous PCAF
and p27 by using anti-PCAF (Figure 1F) or anti-p27
antibodies (Figure 1G).
The PCAF-interacting domain of p27 includes amino acids
91–120 and contains a proline-rich domain
To identify the PCAF-interacting domain (PID) of p27,
afﬁnity chromatography experiments using different p27
fragments were performed. We ﬁrst generated two afﬁnity
columns using the fragments p27–NT (amino acids 1–110)
PCAF
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PCAF
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IP Flag Input
CFP-p27
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Figure 1. Interaction of p27 with PCAF. (A) HCT116 cell extracts were loaded on a p27 or a Sepharose 4B column (Seph.). Proteins not bound
(NB) or bound (B) to the columns were analyzed by WB using an anti-PCAF antibody. (B) Puriﬁed GST–PCAF was loaded on a GST–p27 or on a
GST column. Fractions not bound (NB) or bound (B) to the columns were visualized by gel electrophoresis and Coomassie blue staining.
(C) Puriﬁed GST–HAT was loaded on a GST–p27 or a GST column. Fractions not bound (NB) or bound (B) to the columns were visualized
by gel electrophoresis and coomassie blue staining. (D) NIH3T3 and HeLa cells were cotransfected with CFP–p27 and YFP–PCAF, stained with
DAPI and subsequently visualized by confocal microscopy. Bar: 5 mm (E) HEK293T cells were transfected with Flag–PCAF or/and CFP–p27. At
24 h post-transfection, cell extracts were immunoprecipitated with anti-Flag. Cells transfected with an empty CFP vector (Ø) and Flag–PCAF were
used as a control. The immunoprecipitates were then analyzed by WB using antibodies against PCAF or p27. (F) HEK293T cell extracts were
subjected to IP with anti-PCAF or anti-Flag (as a control), then, the immunoprecipitates were analyzed by WB using antibodies against PCAF or
p27. (G) HEK293T cell extracts were subjected to IP with anti-p27 or anti-Flag (as a control), then, the immunoprecipitates were analyzed by
WB using antibodies against PCAF or p27.
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and p27–CT (amino acids 110–198) (Figure 2A). Puriﬁed
PCAF was loaded onto both columns and its association
analyzed by WB. As shown in Figure 2B (upper and
middle panels), PCAF did not associate with any of
both fragments of p27 indicating that the PID was lost
with fragmentation. In contrast, we observed that PCAF
associates with p27(amino acids 1–135) (Figure 2B,
bottom panel). We subsequently studied the association
of PCAF with the peptides p27(amino acids 91–120)
and p27(amino acids 101–120). Results revealed that
p27(91–120) associated with PCAF whereas p27(amino
acids 101–120) did not (Figure 2C). These data indicated
that the PID is included in the amino acids 91–120 region
of p27. To further conﬁrm that this region corresponds to
the PID of p27 we generated three deletion mutants, spe-
ciﬁcally: p27(91–100), p27(96–100) and p27(91–95)
(Figure 2D). Puriﬁed mutant proteins were loaded onto
a GST–HAT column and the interaction analyzed. As
shown in Figure 2E when a large part of the PID
domain was deleted as in the p27(91–100) mutant, the
association with PCAF was totally lost whereas shorter
deletions as in p27(96–100) and p27(91–95) still
retained the ability to interact with PCAF. Interestingly,
this region includes a proline-rich domain (PRD) (amino
acids 91–96) (Figure 2A) although as shown in Figure 2E
its role in the association with PCAF is not essential. To
validate the PID of p27 in the cells, we used HEK293T
cells that were cotransfected with the deletion mutants
p27(91–100) or p27(91–120) together with Flag–
PCAF and subsequently subjected to IP with anti-Flag.
Results clearly indicated that the interaction of PCAF
with both mutants was strongly reduced (Figure 2F
and G).
PCAF acetylates p27 at Lys 100
To study whether p27 is acetylated by PCAF, in vitro
acetyltransferase assays were performed. Results indicated
that p27 was acetylated in vitro by PCAF (Figure 3A).
Similar experiments showed that PCAF was not able to
acetylate p21Cip1, another member of the Cip/Kip family
of inhibitors (Figure 3B). We also observed that p27 could
not be acetylated by CBP, a protein belonging to another
family of acetyltransferases (Figure 3C).
Next, we studied the acetylation of p27 in the cells by IP
with anti-p27 followed by WB with anti-acetyl-Lys. To
this aim, HEK 293T cells were transfected with CFP–
p27 and PCAF. As a negative control, cells were trans-
fected with a p27 mutant in which all lysines were
substituted by arginines (p27–K13R). Results indicated
that p27WT was acetylated whereas the mutant
p27(K13R) did not (Figure 3D, left panel). Similar experi-
ments revealed that p21 was not acetylated in the cells
(Figure 3D, right panel). Finally, we also observed the
acetylation of endogenous p27 by IP with anti-p27
followed by WB with anti-acetyl-Lys (Figure 3E).
To identify the acetylation site/s of p27 we ﬁrst per-
formed in vitro acetylation assays using two p27 frag-
ments, p27(1–110) and p27(110–198). Results indicated
that p27(1–110) but not p27(110–198) was acetylated
in vitro by PCAF (Figure 4A). The p27(1–110) fragment
contains eight lysine residues at positions K25, K47, K59,
K68, K73, K81, K96 and K100. To identify the residues
that might be acetylated by PCAF, in vitro ‘spot mapping’
experiments were performed. Thus, eight peptides, each
one containing one of the lysines present in this
fragment, were synthesized and spotted on a nitrocellulose
membrane. Additionally, a peptide from histone H3 was
used as a positive control (Figure 4B). Then, this
membrane was subjected to an in vitro acetylation assay
using PCAF as acetylase. Results indicated that the
control peptide and peptides containing K25, K96 and
K100 were acetylated by PCAF (Figure 4C). To analyze
whether these lysines were the acetylation sites in the full-
length p27 protein, mutational analysis were performed.
GST–p27 proteins harboring different K for R substitu-
tions were used as substrates for in vitro acetylation
assays. Results revealed that the triple mutant p27–K3R
(K25R, K96R and K100R), the double mutant p27–2R
(K96R and K100R) and the single mutant p27–K100R
were not acetylated by PCAF (Figure 4D). These results
indicated that K100 in p27 is the speciﬁc acetylation site
for PCAF. Finally, acetylation assays were performed in
HEK293T cells. Cells were transfected with different
forms of p27 and with an empty vector as a control.
Then, after an IP with anti-p27 the acetylation status of
the protein was determined by WB with an anti-
acetyl-lysine. Results revealed that p27WT was acetylated
whereas the mutants p27–K3R or p27K100R did not
(Figure 4E), indicating that K100 is the speciﬁc acetyl-
ation site of p27 also in the cells. As an additional
positive control we also determined the acetylation
status of the mutant p27–K5R (K47R, K59R, K68R,
K73R and K81R) that was acetylated as it can be
observed in Figure 4E. Finally, as a negative control we
tested the acetylation of the mutant p27K13R and of the
mutant p27(91–120) that lacks the PID and K100. As
shown in Figure 4E and F these mutants were not
acetylated.
PCAF associates with and acetylates p27 along the
cell cycle
We subsequently aimed to analyze the functional rele-
vance of p27 acetylation. Thus, we ﬁrst studied by WB
the levels of PCAF along the cell cycle. HeLa cells were
arrested in G0 by serum starvation (0 h) and later on they
were induced to enter the cell cycle by serum addition.
Then, at different times samples were collected and
analyzed by WB with antibodies against PCAF. The
levels of cyclin D1 and p27 were also analyzed to
monitor cell-cycle entry whereas anti-actin was used as a
loading control (Figure 5A). Results from three different
WB with anti-PCAF were quantiﬁed and represented as a
regression line (Figure 5B). Similarly, three different WB
with anti-cyclin D1 and anti-p27 were quantiﬁed and rep-
resented in Figure 5C. These data revealed that the
amount of PCAF remained constant at least during the
ﬁrst 12 h after cell-cycle entry. In contrast, levels of p27
were high in arrested cells (0 h) and progressively
decreased whereas those of cyclin D1 increased along
cell-cycle progression (Figure 5C). We subsequently
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Figure 2. The PID of p27 includes amino acids 91–120. (A) Graphic showing different fragments and domains of p27 used in the experiments.
(B) Puriﬁed PCAF was loaded on GST–p27(1–110), GST–p27(110–198) and GST–p27(1–135) afﬁnity chromatography columns. Then, the input
(PC), the ﬂow trough (FT), the last wash (W) and the eluate (E) fractions were subjected to electrophoresis and visualized by WB. (C) Puriﬁed PCAF
was loaded on p27(101–120) and p27(91–120) afﬁnity chromatography columns. As a control a Sepharose 4B column (Seph.) was used. Then, the
ﬂow trough (FT), the last wash (W) and the eluate (E) fractions were subjected to electrophoresis and visualized by WB. (D) Graphic showing the
three p27 deletion mutants used in the experiments. (E) Puriﬁed p27(91–100), p27(96–100) and p27(91–95) proteins were loaded on a GST–
HAT column. Then, the ﬂow trough (FT), the last wash (W) and the eluate (E) fractions were subjected to electrophoresis and visualized by WB. (F)
HEK293T cells were transfected with YFP–Flag–PCAF plus p27WT or plus the deletion mutants p27(91-100) or p27(91–120) or woth an empty
CFP vector (Ø). Then, cell extracts were subjected to IP with anti-Flag and the immunoprecipitates analyzed by WB with anti-p27 and anti-PCAF.
(G) Experiment in (F) was repeated three times and quantiﬁed. Results were expressed as the mean value±SD. Statistical analyses were performed
using Student’s two-tailed paired t-test. Values of P< 0.05 were considered statistically signiﬁcant. ***P< 0.001.
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determined by IP the association of p27 with PCAF at
different times after serum addition. As shown in
Figure 5D the association between both proteins was
similar in quiescent cells and at different times after pro-
liferative activation. Finally, by IP with anti-p27 followed
by WB with anti-acetyl-lysine we determined the acetyl-
ation of p27 during cell cycle. Results revealed that p27
was slightly acetylated in quiescent cells (0 h) and then
acetylation ﬂuctuates: at 2 h it was signiﬁcantly increased
whereas later on at 4–6 h decreased to subsequently recu-
perate the initial levels of acetylation (Figure 5E). Data
from three different experiments were quantiﬁed and rep-
resented in Figure 5F.
Acetylation of Lysine K100 regulates the Stability of p27
On comparing the kinetics of p27 levels (Figure 5C) and
p27 acetylation (Figure 5F), we observed a correlation
between both parameters during the ﬁrst 6 h after serum
addition to the cell cultures. Thus, we aimed to study
whether acetylation of p27 could play a role on its stabil-
ity. As shown in Figure 6A, knocking down of PCAF, in
HCT116 cells, by a speciﬁc shRNA induced a signiﬁcant
increase of p27. Conversely, overexpression of Flag–
PCAF induced a signiﬁcant decrease of p27. Similar
results were observed when cells overexpressed an active
fragment of PCAF (GFP-CtWT). This decrease of p27
depended on the activity of PCAF because overexpression
of an inactive form (GFP-CtHAT) did not signiﬁcantly
affect the levels of p27 (Figure 6B). These results suggested
that PCAF could regulate the stability of p27. To further
analyze this possibility, we determined the half-life of p27
in HCT116 cells overexpressing PCAF. Results revealed
that the half-life of p27 in these cells was signiﬁcantly
decreased (1.1±0.2 h) as compared to control cells
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Figure 3. PCAF acetylates p27. (A) In vitro acetylation assays were performed by incubating puriﬁed GST–HAT with the indicated concentrations
of puriﬁed GST–p27 in the presence of radioactive acetyl-CoA. Control assays were performed with GST–p27 in the absence of GST–HAT (C),
with GST–HAT in the absence of any substrate () or in the presence of GST. Acetylation was examined by autoradiography (left panel). A WB
using anti-p27 is also showed (right panel). (B) Puriﬁed GST–HAT was incubated with GST–p27, GST–p21 or GST in the presence of radioactive
acetyl-CoA. A similar assay was performed in the absence of any substrate (). Acetylation was examined by autoradiography (left panel). Red
Ponceau stain of the membrane is showed in the right panel. (C) Puriﬁed GST–CBP was incubated with GST–p27, GST or histones in the presence
of radioactive acetyl-CoA. A similar assay was performed in the absence of any substrate (). Acetylation was examined by autoradiography (left
panel). Red Ponceau stain of the membrane is shown in the right panel. (D) HEK293T cells were cotransfected with PCAF plus p27WT or p27K13R,
or transfected with an empty vector (ø). Then, cell extracts were subjected to IP with anti-p27. The levels of total or acetylated p27 were examined by
WB with anti-p27 or anti-acetyl-lysine antibodies (Ac-K), respectively (upper left panel). A similar experiment was performed using p21 instead of
p27 (upper right panel). Expression levels of p27 and p21 were examined by WB (bottom panels). (E) Cell extracts were subjected to IP with anti-p27
or anti-Flag (used as a control) and then the immunoprecipitates were analyzed by anti-p27 and anti-acetyl-Lysine antibodies (Ac-K).
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positive control (peptide 1). (C) The membrane containing the spotted peptides was subjected to an in vitro acetylation assay using GST–HAT as
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staining of the membrane is showed in the right panel. (E) HEK293T cells were transfected with an empty vector (ø) or cotransfected with p27WT,
p27-K13R, p27-K100R, p27-K3R or p27-K5R plus PCAF. Cell extracts were then subjected to IP with anti-p27 and the total levels of p27
or acetylated p27 were analyzed by WB with anti-p27 or anti acetyl-Lysine (Ac-K) antibodies (left panel). Expression levels of the different
forms of p27 were determined by WB with anti-p27 (right panel). (F) Cells were transfected with an empty vector or cotransfected with p27WT
or p27(91–120) plus PCAF. Cell extracts were then subjected to IP with anti-p27 and the levels of p27 or acetylated p27 were analyzed by WB with
anti-p27 or anti-acetyl-Lysine (Ac-K) antibodies (left panel). Expression levels of the different forms of p27 were determined by WB with anti-p27
(right panel).
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(3.3±0.4 h), thereby conﬁrming the effect of PCAF on
the downregulation of p27 (Figure 6C and D). We also
observed that the half-life of the ectopically expressed
non-acetylatable mutant p27-K100R was much higher
(12.4±0.5 h) than that of the endogenous (1.8±0.2 h)
or ectopic p27WT (1.9±0.3 h) (Figure 6E and F),
indicating that Lys100 was necessary for the acetylation
and stability of p27
We subsequently analyzed the behavior of ectopic
p27WT and p27K100R during cell cycle. HCT116 cells
transfected with each one of these forms of p27 were
made quiescent by culturing them with 0.5%
FCS-containing media during 48 h. Then, they were
re-plated and cultured with 10% FCS to induce cell-
cycle entry. Cells were then collected at 10 h after serum
addition. In these experiments cyclin D1 levels were
determined to monitor cell-cycle progression and those
of actin as a loading control. As shown in Figure 7A, at
10 h after proliferative activation, the levels of p27WT
were decreased whereas those of p27K100R remained
similar to the control. These results corroborate that the
non-acetylatable mutant of p27 was more stable than
p27WT at G1. Similar experiments were performed using
the mutant p27(91–120) unable to interact with PCAF
and also non-acetylatable. In this case, we also observed
that at G1, this mutant was more stable than p27WT.
To analyze whether the effect of PCAF on the stability
of p27 was depending on proteasome activity, we added
ALLNL or MG132, speciﬁc inhibitors of the 26 S prote-
asome, to HCT116 cell cultures previously transfected
with Flag–PCAF and then, we checked the levels of p27
protein. Results revealed that in the presence of any of
both proteasome inhibitors, the overexpression of PCAF
did not decrease the levels of p27 (Figure 7C and D).
We subsequently studied the effect of PCAF on p27
ubiquitylation. Thus, we performed an in vitro
ubiquitylation assay using reticulocyte extracts and
puriﬁed p27Kip1 protein in the presence or in the absence
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Figure 5. The p27 protein is acetylated at early G1. (A) HeLa cells were made quiescent by serum starvation for 72 h and then re-plated in the
presence of 10% FCS. Total cell extracts were prepared at the indicated times after cell-cycle resumption. The levels of PCAF and p27 were
examined by WB with anti-PCAF and anti-p27. WB with anti-cyclin D1 was performed to monitor cell-cycle progression and WB with anti-actin was
performed as a loading control. (B) PCAF levels from three different experiments described in (A) were quantiﬁed and expressed as a regression line.
(C) cyclin D1 and p27 levels from three different experiments described in (A) were quantiﬁed and expressed as the mean value±SD. (D) HeLa cell
extracts from the indicated times were subjected to IP with anti-p27 and the levels of PCAF and p27 in the immunoprecipitates were determined by
WB. (E) Extracts from HeLa cells at different times after cell-cycle resumption were subjected to IP with anti-p27. Then, the levels of p27 and those
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Figure 6. PCAF induces p27 degradation. (A) HCT116 cells were knocked down for PCAF by using a speciﬁc shRNA whereas an unrelated shRNA
was used as a control (shC). Then, the levels of PCAF and p27 were determined by WB with anti-PCAF and anti-p27. WB with anti-actin was used
as a loading control (left panel). Results from three different experiments were quantiﬁed and expressed as the mean value±SD. Statistical analyses
were performed using Student’s two-tailed paired t-test. **P< 0.01 (right panel). (B) HCT116 cells were transfected with expression vectors for GFP
(C), Flag–PCAF, GFP-Flag-CtWT or for its inactive form GFP-Flag-CtHAT. At 24 h post-transfection, the levels of p27 and the ectopic Flag–
PCAF were examined by WB with anti-p27 or anti-Flag, respectively. WB with anti-actin was performed as a loading control (left panel). Results
from three different experiments were quantiﬁed and expressed as the mean value±SD. Statistical analyses were performed using Student’s
two-tailed paired t-test. **P< 0.01 (right panel). (C) HCT116 cells were transfected with Flag–PCAF or with an empty vector (Ø) as a control.
At 24 h post-transfection, cycloheximide (CHX) was added to the cell cultures and then, at the indicated times the levels of PCAF and p27 were
examined by WB with an anti-PCAF or anti-p27, respectively. WB with anti-actin was performed as a loading control. (D) The intensities of p27
signals from three independent experiments were quantiﬁed, normalized for actin and plotted. Results are expressed as percentage relative to levels
observed at Time 0. Statistical analyses were performed using Student’s two-tailed paired t-test. In all points P< 0.05. (E) HCT116 cells were
transfected with p27WT or p27-K100R. Transfection with the empty vector (Ø) was used as a control. At 24 h post-transfection, CHX was added to
the cell cultures and then, at the indicated times the levels of endogenous PCAF and ectopic p27WT or p27-K100R were examined by WB with
anti-PCAF or anti-p27, respectively. WB with anti-actin was performed as a loading control. (F) The intensities of p27 signals from three inde-
pendent experiments were quantiﬁed, normalized for actin and plotted. Results are expressed as percentage relative to levels observed at Time 0.
Statistical analyses were performed using Student’s two-tailed paired t-test. In all points, when comparing ectopic p27WT or endogenous p27 versus
p27K100R, P< 0.01.
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of active PCAF. Results revealed that acetylation by
PCAF induced the ubiquitylation of p27 (Figure 7E).
This ubiquitylation depends on Lys100 residue in p27
because the mutant p27-K100R was not ubiquitylated in
the same experimental conditions (Figure 7E). Finally, we
studied whether degradation of p27 induced by PCAF was
mediated by Skp2, an F-box protein involved in the rec-
ognition of p27 facilitating its ubiquitylation by the
SCFSkp2 complex (25). Thus, HCT116 cells were treated
with siRNA for Skp2 and then transfected with
FlagPCAF. Results indicated that the treatment with
siRNA reduced Skp2 and increased the levels of p27
(Figure 7F, lanes 1 and 3). We also observed that the
overexpression of PCAF decreased the levels of p27Kip1
in cells with normal amounts of Skp2, but also in cells
with low levels of this protein, indicating that degradation
of p27 induced by PCAF is independent of Skp2
(Figure 7F, lanes 2 and 4).
A
C
E
B
D
F
Figure 7. Acetylation of K100 in p27 induces its degradation via proteasome. (A) HCT116 cells were transfected with GFPp27WT or
GFPp27K100R and then made quiescent by serum starvation for 48 h. Then, they were released from quiescence by serum addition. Cell
samples were collected at Time 0 and at 10 h after re-entry into cell cycle. The levels of these two forms of p27 were detected by WB using
anti-GFP. Cyclin D1 was detected by WB to monitor cell-cycle progression and WB with anti-actin was performed as a loading control. (B) HCT116
cells were transfected with GFPp27WT or GFPp2791–120 and then made quiescent by serum starvation for 48 h. Then, they were released from
quiescence by serum addition. Cell samples were collected at Time 0 and at 10 h after re-entry into cell cycle. The levels of these two forms of p27
were detected by WB using anti-GFP. Cyclin D1 was detected by WB to monitor cell-cycle progression and WB with anti-actin was performed as a
loading control. (C) HCT116 cells were transfected with Flag–PCAF or with the empty vector as a control. At 8 h post-transfection, cells were
additionally incubated for 16 h in the presence or in the absence of the proteasome inhibitor ALLN. Then, the levels of PCAF and p27 in the total
cell extracts were examined by WB. WB with anti-actin was performed as a loading control. (D) HCT116 cells were transfected with Flag–PCAF or
with the empty vector as a control. At 8 h post-transfection, cells were additionally incubated for 16 h in the presence or in the absence of the
proteasome inhibitor MG132. Then, the levels of PCAF and p27 in the total cell extracts were examined by WB. WB with anti-actin was performed
as a loading control. (E) PCAF stimulates the in vitro ubiquitylation of p27. Puriﬁed recombinant GSTp27WT or GSTp27-K100R proteins were
incubated with radioactive acetyl-CoA and GSTHAT protein for in vitro acetylation reaction in the presence of reticulocyte lysates. After incubation,
the proteins from the reticulocyte lysates were eliminated by purifying the GST-containing proteins with a glutathione column. The 50% of the
material was analyzed for ubiquitylation by WB with anti-ubiquitin antibody (right panel). The other 50% of the material was used for the analysis
of the acetylation of p27 by autoradiography (left panel). (F) The levels of endogenous Skp2 were down-regulated by incubating HCT116 cells with
siRNA for Skp2 (siSkp2) during 48 h. Incubation with siRNA for GFP (siGFP) was used as a control. Then, cells were transfected with FlagPCAF
expression vector. At 20 h post-transfection, the levels of Flag PCAF, Skp2, p27 and actin were determined in the cell extracts by WB using speciﬁc
antibodies.
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DISCUSSION
Here we investigated the role of acetylation on p27 stabil-
ity. We describe that p27 directly interacts with PCAF
forming complexes in the cells, mostly located in the
nucleus. This is consistent with previous reports showing
that PCAF essentially displays a nuclear localization (26).
We provide evidence that p27 associates with the catalytic
domain (HAT) of PCAF through a region including
amino acids 91–120 that we named PID. Despite the
deletion p27 mutant, lacking a region including amino
acids 91–100 loses the ability to interact with PCAF
(Figure 2E), the fact that PCAF did no interact with the
p27NT(1–110) fragment indicates that the domain amino
acids 110–120 is also necessary for the interaction and thus
the full PID of p27 has to considered to include amino
acids 91–120.
Interestingly, this region contains a PRD (amino acids
91–95) known to interact with proteins containing a Src
homology 3 (SH3) domain. The PRD of p27 has been
reported to interact with other proteins that are relevant
for cell-cycle control as for instance Grb2 (27). These data
are in agreement with previous observations showing that
the HAT domain of GNC5, an acetyltransferase present-
ing high homology with PCAF, has a structure similar to
an SH3 domain (28,29). Due to this high homology, it can
be assumed that PCAF also has this structure that would
facilitate the association with the PRD of p27. However,
as shown in Figure 2E the interaction of PCAF with this
domain of p27 is not critical because when it was deleted
the association of PCAF with p27 was only slightly
affected.
We further conﬁrmed that the PID domain of p27
includes amino acids 91–120 by transfecting the deletion
mutants p27(91–100) or p27(91–120) into the cells and
analyzing their interaction with PCAF. As shown in
Figure 2F and G, the interaction of PCAF with these
mutants was strongly reduced. The residual interaction
of PCAF with these mutants can be attributed to the
indirect interaction through cyclin A–cdk2 complexes.
We previously reported that PCAF directly interacts
with both cyclin A and cdk2 (6,30). Since these p27
mutants (p2791–100 and p2791–120) still retain the
ability to associate with cyclins and cdks, the IP with
anti-Flag immunoprecipitate the cyclin A and cdk2
associated with PCAF and additionally the p27 associated
with cyclin A and cdk2.
We identiﬁed K100 as the speciﬁc residue of p27
acetylated by PCAF in vitro and in the cells. K100 is
very close to the PRD (amino acids 91–95) and it is
included in the PID of p27. Thus, this is consistent with
a scenario in which PCAF through its HAT domain asso-
ciates with the PID of p27 and acetylates K100 included in
this region.
Degradation of p27 is produced by ubiquitin-dependent
proteolysis in a two-step process (31). The ﬁrst step takes
place during G0/G1 transition and early-mid G1, is inde-
pendent of phosphorylation at T187 of p27 and it is
mediated by the ubiquitin ligase KPC (32,33). However,
the molecular signal triggering this degradation still
remains unclear.
In contrast, the second proteolytic step is produced
during G1/S transition and S and G2 phases and it is de-
pendent on phosphorylation at T187 by cyclin E–Cdk2
(34,35). This second step is preceded by the phosphoryl-
ation of p27 at three speciﬁc tyrosine residues: Y74, Y88
and Y89. This allows to the p27-associated cyclin E–Cdk2
complexes to be partially activated. Then, these complexes
can phosphorylate the T187 of p27 inducing its
ubiquitin-dependent degradation (36,37). Interestingly,
these tyrosine residues are very close to the PRD of p27.
Moreover, the tyrosine kinases, members of the Src family
(i.e. c-Src, Bcr-Abl, Lyn) that phosphorylate these p27
tyrosine residues have an SH3 domain that allows the
interaction with the PRD of p27 (38–41). Collectively,
these results indicate a key participation of the PID
(a region including amino acids 91–120) of p27 in the
regulation of its stability: by associating with PCAF and
acetylating K100 and by interacting with tyrosine kinases
that phosphorylate Y74, Y88 and/or Y89 thus allowing
the further phosphorylation of T187.
We propose that degradation of p27 mediated by acetyl-
ation could operate during G1. We observed that the
knockdown of PCAF increases the levels of p27 and con-
versely overexpression of PCAF decreases its amount.
Moreover, we also observed that the half-life of p27 is
decreased when PCAF is overexpressed and than that of
the non-acetylatable mutant p27K100R is higher than that
of p27WT. Moreover, as shown in Figure 7, we observed
that differently to p27WT, the non-acetylatable mutants
p27K100R and p2791–120 were not degraded
during G1.
We also report here several evidences indicating that the
acetylation induced p27 degradation could be performed
via proteasome. Speciﬁcally, we describe that proteasome
inhibitors as ALLN and MG132 block the p27 degrad-
ation induced by PCAF overexpression and that p27
acetylation by PCAF induced its K100 dependent
ubiquitylation, because the non-acetylatable p27K100R
mutant was not ubiquitylated under the same experimen-
tal conditions (Figure 7E). The observation that the levels
of acetylated p27 correlates with the levels of p27 during
the ﬁrst 6 h after mitogenic stimulation of the cells
(Figure 5C and F) also supports the relationship
between acetylation and degradation during G1. These
results indicate that there is a basal acetylation of p27 in
quiescent cells. A possibility is that this basal acetylation
could be related to a basal turn over of the protein in the
nucleus. At 2 h an increase of p27 acetylation was
observed by WB. Interestingly, at this point the levels of
p27 are still high (Figure 5C). This indicates that at this
point degradation still has not been initiated and suggests
that p27 is already targeted for its subsequent degradation
that will immediately start. This is supported by the fact
that at times 4–6 h the total levels of p27 are progressive
decreasing concomitantly with the decrease of acetylated
p27. This indicates that speciﬁcally is the acetylated form
of p27 the one that is degraded at that time. Finally, at
times 8–10 h the subsequent degradation of p27 is
probably performed via phosphorylation of T187 via
Skp2 that is produced later on at the late G1 and G1/S
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transition. At this point acetylation of p27 returns to its
basal levels.
Interestingly, we also report here that the acetylation
dependent degradation of p27 is independent of Skp2
(Figure 7F). These data also support the role of acetyl-
ation induced degradation of p27 during G1. Finally, it
has been reported that a domain of p27 including amino
acids 42–102 is necessary for the ubiquitylation and deg-
radation of p27 mediated by the E-ubiquitin ligase KPC at
G0/G1 (33). Our results indicating that K100 is included in
this domain are compatible with the possibility that acetyl-
ation could signal p27 for recognition by KPC at G0/G1.
Another mechanism involved in the degradation of p27
during G1 related to the activation of the Wnt–Cul4A
pathway has been reported (42). However, the possibility
that acetylation of p27 could participate in this mechanism
remains to be explored.
The functional relevance of p27 acetylation on its role
on transcription still remains to be explored. However,
because p27 is a transcriptional repressor of its target
genes, our data showing that acetylation at K100 by
PCAF induces its degradation allows us to speculate
that it would facilitate the expression of the p27-TGs.
This speculation is compatible with the well-known role
of PCAF as a transcriptional coactivator. Experiments to
clarify this point are currently underway in our
laboratory.
We also speculate that this new mechanism regulating
p27 stability could be also relevant during oncogenesis. It
is known that p27 is decreased in many human tumors
correlating with a bad prognosis (43,44). In a number of
cases, this decrease has been correlated with increased
levels of Skp2 that mediates p27 degradation at S/G2.
However, in other cases, this correlation could not be es-
tablished. Results reported here allow us to speculate that
the decrease of p27 levels in tumor cells could be also
produced by alterations in its acetylation status.
In conclusion, we describe here a new mechanism
regulating p27 stability that involves acetylation of K100
of p27. We postulate that this new mechanism could be
relevant for the transcriptional regulatory role of p27.
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